-+ 0.00%
-+ 0.00%
-+ 0.00%
Brightlands-backed Hy2Care prepares US clinical trial for knee cartilage implant
Share
Listen to the news
Brightlands-backed Hy2Care prepares US clinical trial for knee cartilage implant
  • Hy2Care is preparing a U.S. clinical trial for its CartRevive knee cartilage implant following EUR 4.5 million in financing in 2025.
  • Noah Labs, which develops voice biomarkers for heart failure monitoring, received FDA Breakthrough Device Designation earlier this year.
  • Both companies appeared on the Nasdaq billboard in Times Square as members of the MedTech Innovator 2026 cohort.
  • The cohort comprised 65 companies selected from 1,835 applicants.
  • Vivalyx, which develops organ transplantation technology, was featured in Handelsblatt among North Rhine-Westphalia’s top startups.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Brightlands Venture Partners BV published the original content used to generate this news brief on November 19, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending